Aptahem attends the BioStock Life Science Summit on 31 May 2023
Aptahem’s CEO Mikael Lindstam is presenting the company and gives an update on the ongoing activities. The presentation, which is held in English, can be followed online on 31 May at 12.50 CET.More information about the event is available on the BioStock Life Science Summit website: https://www.biostock.se/en/biostock-life-science-summit-may-2023/ For further information: Aptahem ABMikael Lindstam, CEOTel: +46 (0)766-33 36 99E-mail: ml@aptahem.com About Aptahem Aptahem AB (APTA) is a clinical stage biotechnology company that develops aptamer-based pharmaceuticals for